Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]The Netherlands Cancer Institute"
Count: 268
Selected: 0
| NCT ID | Title |
|---|
| NCT05772923 | Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision | ||
| NCT05209750 | FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma | ||
| NCT05200988 | Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC | ||
| NCT03686332 | PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study | ||
| NCT03871036 | Improve Checkpoint-blockade Response in Advanced Urothelial Cancer | ||
| NCT05120973 | Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer. | ||
| NCT03772028 | Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | ||
| NCT01164995 | Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer | ||
| NCT06012734 | LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients | ||
| NCT04518124 | Propranolol in Angiosarcoma | ||
| NCT03984019 | Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis | ||
| NCT05982678 | Basket Study for Oligo-metastatic Breast Cancer | ||
| NCT04699292 | International Prospective Registry on Local Treatment Approaches in MLS | ||
| NCT04425967 | Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas | ||
| NCT02910895 | A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS) | ||
| NCT01504815 | Adaptive Radiation Treatment for Head and Neck Cancer | ||
| NCT05301881 | COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study | ||
| NCT05827289 | 'Cancer Patients Better Life Experience' | ||
| NCT03968679 | Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer | ||
| NCT05918341 | Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker | ||
| NCT05905315 | Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC | ||
| NCT05518799 | CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours | ||
| NCT05867095 | Navigated Abdominal Lymph Node Dissections | ||
| NCT05705921 | Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer | ||
| NCT04871594 | Pre-operative Immunotherapy in Stage II-III Urothelial Cancer | ||
| NCT05400954 | Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases | ||
| NCT05116254 | Sarcomas and DDR-Inhibition; a Combined Modality Study | ||
| NCT03223727 | Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 | ||
| NCT03819829 | Blood Sampling of Healthy Volunteers for Immunological Research | ||
| NCT03815890 | Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO | ||
| NCT02810743 | Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer | ||
| NCT01996267 | Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 | ||
| NCT01898117 | Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer | ||
| NCT05638152 | Effect of a Bundle of Non-pharmacological Interventions on the Stress Response to Surgery | ||
| NCT05620199 | Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy | ||
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | ||
| NCT05710133 | The Food-effect on Alectinib Pharmacokinetics | ||
| NCT04180033 | Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy | ||
| NCT05700656 | Galunisertib Combined With Capecitabine in Advanced CRC With PM | ||
| NCT03026140 | Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer | ||
| NCT04071704 | Assessing Health-related Quality of Life in Sarcoma Patients | ||
| NCT04287829 | Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients | ||
| NCT05401786 | Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC | ||
| NCT05314309 | Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening | ||
| NCT05131919 | Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers | ||
| NCT05637359 | Tracked Ultrasound for Patient Registration in Surgical Navigation During Abdominal Cancer Surgery | ||
| NCT05637346 | Vessel-based Ultrasound Registration | ||
| NCT03784599 | T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC | ||
| NCT03727724 | Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer | ||
| NCT03564197 | 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC |
